Depreciation of Sage Therapeutics, Inc. from 31 Dec 2013 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Sage Therapeutics, Inc. quarterly and annual Depreciation in USD history and change rate from 31 Dec 2013 to 31 Mar 2025.
  • Sage Therapeutics, Inc. Depreciation for the quarter ending 31 Mar 2025 was $112,000, a 67% decline year-over-year.
  • Sage Therapeutics, Inc. annual Depreciation for 2024 was $1,031,000, a 26% decline from 2023.
  • Sage Therapeutics, Inc. annual Depreciation for 2023 was $1,393,000, a 24% increase from 2022.
  • Sage Therapeutics, Inc. annual Depreciation for 2022 was $1,122,000, a 73% decline from 2021.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Sage Therapeutics, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $112,000 -$224,000 -67% 01 Jan 2025 31 Mar 2025 10-Q 29 Apr 2025 2025 Q1
Q1 2024 $336,000 +$13,000 +4% 01 Jan 2024 31 Mar 2024 10-Q 29 Apr 2025 2025 Q1
Q1 2023 $323,000 +$48,000 +17% 01 Jan 2023 31 Mar 2023 10-Q 25 Apr 2024 2024 Q1
Q1 2022 $1,875,000 $275,000 -$2,307,000 -89% 01 Jan 2022 31 Mar 2022 10-Q 02 May 2023 2023 Q1
Q4 2021 $4,182,000 $300,000 -$261,000 -47% 01 Oct 2021 31 Dec 2021 10-K 14 Feb 2024 2023 FY
Q3 2021 $4,443,000 $400,000 -$300,000 -43% 01 Jul 2021 30 Sep 2021 10-Q 02 Nov 2021 2021 Q3
Q2 2021 $4,743,000 $900,000 +$200,000 +29% 01 Apr 2021 30 Jun 2021 10-Q 03 Aug 2021 2021 Q2
Q1 2021 $4,543,000 $2,582,000 +$1,913,000 +286% 01 Jan 2021 31 Mar 2021 10-Q 03 May 2022 2022 Q1
Q4 2020 $2,630,000 $561,000 -$107,000 -16% 01 Oct 2020 31 Dec 2020 10-K 16 Feb 2023 2022 FY
Q3 2020 $2,737,000 $700,000 $0 0% 01 Jul 2020 30 Sep 2020 10-Q 02 Nov 2021 2021 Q3
Q2 2020 $2,737,000 $700,000 +$200,000 +40% 01 Apr 2020 30 Jun 2020 10-Q 03 Aug 2021 2021 Q2
Q1 2020 $2,537,000 $669,000 +$254,000 +61% 01 Jan 2020 31 Mar 2020 10-Q 04 May 2021 2021 Q1
Q4 2019 $2,283,000 $668,000 +$272,000 +69% 01 Oct 2019 31 Dec 2019 10-K 24 Feb 2022 2021 FY
Q3 2019 $2,011,000 $700,000 +$400,000 +133% 01 Jul 2019 30 Sep 2019 10-Q 05 Nov 2020 2020 Q3
Q2 2019 $1,611,000 $500,000 +$300,000 +150% 01 Apr 2019 30 Jun 2019 10-Q 10 Aug 2020 2020 Q2
Q1 2019 $1,311,000 $415,000 +$168,000 +68% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020 2020 Q1
Q4 2018 $1,143,000 $396,000 01 Oct 2018 31 Dec 2018 10-K 24 Feb 2021 2020 FY
Q3 2018 $300,000 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019 2019 Q3
Q2 2018 $200,000 01 Apr 2018 30 Jun 2018 10-Q 06 Aug 2019 2019 Q2
Q1 2018 $247,000 +$117,000 +90% 01 Jan 2018 31 Mar 2018 10-Q 02 May 2019 2019 Q1
Q1 2017 $130,000 +$89,000 +217% 01 Jan 2017 31 Mar 2017 10-Q 03 May 2018 2018 Q1
Q1 2016 $41,000 +$19,000 +86% 01 Jan 2016 31 Mar 2016 10-Q 10 May 2017 2017 Q1
Q1 2015 $22,000 01 Jan 2015 31 Mar 2015 10-Q 06 May 2016 2016 Q1

Sage Therapeutics, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $1,031,000 -$362,000 -26% 01 Jan 2024 31 Dec 2024 10-K 11 Feb 2025 2024 FY
2023 $1,393,000 +$271,000 +24% 01 Jan 2023 31 Dec 2023 10-K 11 Feb 2025 2024 FY
2022 $1,122,000 -$3,060,000 -73% 01 Jan 2022 31 Dec 2022 10-K 11 Feb 2025 2024 FY
2021 $4,182,000 +$1,552,000 +59% 01 Jan 2021 31 Dec 2021 10-K 14 Feb 2024 2023 FY
2020 $2,630,000 +$347,000 +15% 01 Jan 2020 31 Dec 2020 10-K 16 Feb 2023 2022 FY
2019 $2,283,000 +$1,140,000 +100% 01 Jan 2019 31 Dec 2019 10-K 24 Feb 2022 2021 FY
2018 $1,143,000 +$612,000 +115% 01 Jan 2018 31 Dec 2018 10-K 24 Feb 2021 2020 FY
2017 $531,000 +$250,000 +89% 01 Jan 2017 31 Dec 2017 10-K 27 Feb 2020 2019 FY
2016 $281,000 +$166,000 +144% 01 Jan 2016 31 Dec 2016 10-K 19 Feb 2019 2018 FY
2015 $115,000 +$64,000 +125% 01 Jan 2015 31 Dec 2015 10-K 22 Feb 2018 2017 FY
2014 $51,000 +$4,000 +8.5% 01 Jan 2014 31 Dec 2014 10-K 24 Feb 2017 2016 FY
2013 $47,000 01 Jan 2013 31 Dec 2013 10-K 29 Feb 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.